NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $2.02 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
INSTITUTIONAL OWNERSHIP
Institutional holders196
Shares held50,164,574
Value$148.64M
Percent of shares outstanding54.12%
As of quarter end2026-06-30
RECENT NEWS
AVXL: Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVXL
AVXL: ROSEN, A LONGSTANDING LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
AVXL CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Anavex Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit